Nucor (NUE) (OPTR) (NFX) (NUAN) (LNKD) (MRX) Ratings Reiterated

Nucor Co. (NYSE: NUE), Optimer Pharmaceuticals (NASDAQ: OPTR), Newfield Exploration Co. (NYSE: NFX), Nuance Communications Inc. (NASDAQ: NUAN), Linkedin Co. (NASDAQ: LNKD) and Medicis Pharmaceuticals (NYSE: MRX) had ratings on them reiterated by analysts.

Robert W. Baird reiterated its "Outperform" rating on Optimer Pharmaceuticals (OPTR).

Jefferies (NYSE:JEF) reiterated its "Hold" rating on Newfield Exploration Co. (NFX). They have a price target of $43.00 on the company.

Wedbush reiterated its "Underperform" rating on Nuance Communications Inc. (NASDAQ: NUAN). They have a price target of $18.00 on the company.

Bank of America (NYSE:BAC) reiterated its "Buy" rating on Nucor Co. (NUE). They have a price target of $48.00 on the company.

Linkedin Co. (LNKD) was given a new price target of $100.00 by Morgan Stanley (NYSE:MS).

Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Medicis Pharmaceuticals (MRX). They have a price target of $44.00 on the company.